Top Markets
#1 Black Phoenix Black Phoenix +354.91%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +75.96%
#4 Gold Park Gold Park +62.07%
#5 OpenEden OpenEden +51.46%
#6 Acurast Acurast +32.03%
#7 BasedHype BasedHype +27.15%
#8 Avantis Avantis +21.77%
#9 Cryptopia Cryptopia +21.54%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.03%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Solvonis Therapeutics plc Solvonis Therapeutics plc

Solvonis Therapeutics plc

SVNS
Pozycja w akcjach #40469
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January... Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with materials such as fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste. GRAFTALEN: These are reactive solid super-concentrates engineered to enhance polyolefin rheology, boost e-modulus, act as chain extenders for PET/PBT, and serve as AOX masterbatches. GRAFTAPOR: Comprising porous polymer-carriers, this line is specifically developed for applications involving liquid chemicals. GRAFTAMID: This series includes high-temperature elastomers, based on nanostructured polyolefin-polyamide alloys. They function as advanced hardening modifiers within polyamide compounds or as standalone components in hot melt adhesive formulations. GRAFTAKIT: Offering reactive liquid or solid super-concentrates embedded in polymeric porous media, GRAFTAKIT is used to optimize reaction extrusion and the modification of compounds. GRAFTALLOY: A range of polymer-polymer nano-alloys crafted to significantly improve abrasion and temperature resistance, boost impact strength, and reduce friction. GRAFTASYNT: This line encompasses synthetic products, notably including halogen-free flame retardants. GRAFTAMER: An innovative smart polymer characterized by thermo-reversible crosslinking, self-hardening, self-healing properties, and shape memory capabilities. The company was founded in 2017 and maintains its headquarters in London, United Kingdom.
Cena akcji
$0.00204105
Kapitalizacja rynkowa
$138.92K
Zmiana (1 dzień)
5.63%
Zmiana (1 rok)
-60.44%
Kraj
GB
Handel Solvonis Therapeutics plc (SVNS)

Kategoria

Industrials
Historia podziałów akcji dla Solvonis Therapeutics plc (SVNS)
Akcje Solvonis Therapeutics plc (symbol: SVNS) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Aug 13, 2026.
Jedna akcja SVNS kupiona przed Aug 13, 2026 odpowiada dziś 0 akcjom SVNS.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
Lam Research Corp. R Lam Research Corp. R
Lam Research Corp. R
LAR0.DE
 0 -
US
Siemens AG Siemens AG
Siemens AG
SIE.DE
 2 x15
DE
Schneider Electric S.E. Schneider Electric S.E.
Schneider Electric S.E.
SU.PA
 0 -
FR
Siemens Energy AG Siemens Energy AG
Siemens Energy AG
ENR.DE
 0 -
DE
Parker-Hannifin Corporation Parker-Hannifin Corporation
Parker-Hannifin Corporation
PH.US
 6 x11
US